Cognitive, neurophysiological, neurological and psychosocial outcomes in early-treated PKU-patients: a start toward standardized outcome measurement across development.
about
Phenylketonuria: translating research into novel therapiesAge-related psychophysiological vulnerability to phenylalanine in phenylketonuria.Dietary amino acid intakes associated with a low-phenylalanine diet combined with amino acid medical foods and glycomacropeptide medical foods and neuropsychological outcomes in subjects with phenylketonuria.Physiological Competition of Brain Phenylalanine Accretion: Initial Pharmacokinetic Analyses of Aminoisobutyric and Methylaminoisobutyric Acids in Pah(enu2-/-) Mice.Relationship between age and white matter integrity in children with phenylketonuria.Tetrahydrobiopterin responsiveness in phenylketonuria: prediction with the 48-hour loading test and genotype.Neurocognitive outcome in tyrosinemia type 1 patients compared to healthy controlsErythrocyte-mediated delivery of recombinant enzymes.Nutrition education tools used in phenylketonuria: clinician, parent and patient perspectives from three international surveys.A Multiplatform Metabolomics Approach to Characterize Plasma Levels of Phenylalanine and Tyrosine in Phenylketonuria.The impact of phenylalanine levels on cognitive outcomes in adults with phenylketonuria: Effects across tasks and developmental stages.The complete European guidelines on phenylketonuria: diagnosis and treatment.
P2860
Q27015749-F5ED8093-27DA-40B4-AF18-36E90116802BQ30435275-557DA05C-F01D-42E9-994A-22C8E4E74762Q33825127-F5C88031-F8CA-49E2-90A2-6B4B73810BB3Q35774242-E3FF3F6E-59AE-48EB-B3A1-4B29C92FE14CQ36799214-A9F6AB4E-2771-454D-B901-55AB2F29985DQ37014366-E00C4A6B-3FAA-4E35-9AD3-F97EC2F5B91FQ37054911-43696271-1D97-4EEE-BD88-56044EA038F2Q38793040-B9113D0E-5C6C-4DE2-BB7C-A273A8D0C68DQ39431877-3943A2DE-642B-4F04-8A25-DE9FB260ED68Q42148990-6D31C813-E3CC-4281-B01C-33EE74D5A53BQ42319019-064D7A9B-5E43-4517-B7DB-6ECCDBF5C864Q42376686-F08A192C-4779-4F54-B694-D26B6ADFAF86
P2860
Cognitive, neurophysiological, neurological and psychosocial outcomes in early-treated PKU-patients: a start toward standardized outcome measurement across development.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cognitive, neurophysiological, ...... easurement across development.
@en
Cognitive, neurophysiological, ...... easurement across development.
@nl
type
label
Cognitive, neurophysiological, ...... easurement across development.
@en
Cognitive, neurophysiological, ...... easurement across development.
@nl
prefLabel
Cognitive, neurophysiological, ...... easurement across development.
@en
Cognitive, neurophysiological, ...... easurement across development.
@nl
P50
P1476
Cognitive, neurophysiological, ...... measurement across development
@en
P2093
F J van Spronsen
P304
P356
10.1016/J.YMGME.2011.09.036
P478
P577
2011-10-06T00:00:00Z